Source link : https://newshealth.biz/health-news/optimizing-perioperative-therapy-in-triple-negative-breast-cancer/
The treatment landscape for early-stage triple-negative breast cancer (TNBC) continues to evolve with evidence from ongoing neoadjuvant and adjuvant therapy trials. A major development was the KEYNOTE-522 trial that established pembrolizumab (Keytruda) plus neoadjuvant chemotherapy as a new standard of care for early TNBC. “The KEYNOTE-522 trial is a pivotal trial that for the first […]
The post Optimizing Perioperative Therapy in Triple-Negative Breast Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-10 15:18:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8